AuraSense Therapeutics is a development-stage biotechnology company founded to pursue the unique commercial potential of Spherical Nucleic Acid (SNA™) constructs. These novel constructs possess unparalleled biocompatibility and versatility as therapeutics. They hold great promise for combating the most threatening diseases in existence, including heart disease, cancer, skin conditions and bacterial infection.
.
